Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-29

Clinical Trial Update: Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial results for Tegoprubart in patients undergoing kidney transplantation, reporting safety and efficacy for preventing or treating kidney transplant …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tegoprubart

Snippet

Sponsor: Eledon Pharmaceuticals | Conditions: Kidney Transplant Rejection | Phase 2 | Status: COMPLETED